Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) shares reached a new 52-week high on Monday . The company traded as high as $30.60 and last traded at $30.53, with a volume of 2094 shares. The stock had previously closed at $30.0950.
Wall Street Analysts Forecast Growth
A number of research firms have weighed in on OTSKY. Morgan Stanley raised Otsuka to an “overweight” rating in a research note on Friday, January 23rd. Zacks Research raised shares of Otsuka from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 9th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Strong Buy”.
Read Our Latest Report on Otsuka
Otsuka Price Performance
About Otsuka
Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.
Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.
Read More
- Five stocks we like better than Otsuka
- Your Signature Is Missing – Act Before It’s Too Late
- Buy This Stock at 9:30 AM on MONDAY!
- What Expenses Can Be Deducted From Capital Gains Tax?
- Buy this Gold Stock Before May 2026
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
